FOXK1 and neoplasm: The experimental study by Huang et al. (2022) demonstrated that miR-16-5p is significantly downregulated in CRC tissues compared with adjacent normal mucosa, and that it acts as a potent tumor suppressor by targeting FOXK1 and inhibiting the PI3K/Akt/mTOR pathway [17].